FDMT: Prakiraan gabungan firma investasi 4D Molecular Therapeutics Inc

4D Molecular Therapeutics (FDMT) develops unique transport systems for delivering genetic material in the treatment of eye and heart pathologies using directed virus evolution methods. The price history on the GURU.Markets chart, where the indicator stands at 28.18, confirms the value of patent protection against competitors. Financial success is based on partnerships with behemoths such as Roche and insurance company payouts for innovative drugs.

FDMT 4D Molecular Corp: Target konsensus ing interval 04.07.2022 - 22.10.2026

Rincian metrik lan analitis perusahaan 4D Molecular Therapeutics Inc (FDMT)

Ringkesan indikator lan parameter pambiji 4D Molecular Therapeutics (FDMT):

Bagan kutipan 4dmoleculartherapeutics.com|FDMT - Prakiraan konsensus analis|Kapitalisasi pasar 4D Molecular Therapeutics Inc

Analisis umum perusahaan:FDMT 4dmoleculartherapeutics.com

Produk sing diprodhuksi 4dmoleculartherapeutics.com

Amid high volatility in the biotech sector, capital protection requires an analysis of market expectations regarding the future value of assets. Steady interest in the unique vector platform of 4D Molecular Therapeutics (FDMT) within closed clinical trials determines the average market target price, which aggregates expert forecasts on the business's fundamental value, helping investors differentiate real growth potential from speculative price overheating.

Pesaing 4D Molecular Therapeutics (FDMT)

TEM: Bagan tingkat prakiraan|Prakiraan konsensus analis QGEN (Qiagen)|IONS: Prakiraan gabungan firma investasi|RGEN - Bagan rega target|Avidity Corp (RNA) - Target konsensus|CRSP (CRISPR Therapeutics AG) - Target konsensus|WGS: Rega prakiraan analis|RARE (Ultragenyx) - Prakiraan konsensus analis|Prakiraan gabungan firma investasi BEAM (Beam Therapeutics Inc)|Bagan rega target Sarepta Therapeutics Inc (SRPT)|Twist Bioscience Corp - Prakiraan gabungan firma investasi|Prakiraan konsensus analis TXG (10x Genomics, Inc.)|Prakiraan konsensus analis intelliatx.com NTLA|Stoke Therapeutics, Inc. (STOK) - Prakiraan gabungan firma investasi|BLFS - Prakiraan konsensus analis|Prakiraan gabungan firma investasi Wave Life Sciences Corp|Target konsensus Maze Therapeutics Corp|SION - Konsensus nilai wajar|Bagan rega target PRME|Target konsensus TSHA (Taysha Gene Therapies, Inc.)|Bagan rega target QURE (uniQure NV)|MGTX: Rata-rata rega prakiraan|REGENXBIO Corp - Bagan rega target|SLDB - Bagan rega target|OCGN - Prakiraan konsensus analis|Rata-rata rega prakiraan PACB|Benitec Biopharma Inc (BNTC) - Prakiraan konsensus analis|Target konsensus DSGN|Target konsensus Rocket Corp (RCKT)|Prakiraan konsensus analis LXEO|Bagan rega target KRRO (korrobio.com)|Bagan rega target Editas Medicine EDIT|Prakiraan konsensus analis Silence Therapeutics PLC SLN|ProQR Therapeutics NV - Prakiraan konsensus analis|CDXS: Bagan rega target|Konsensus nilai wajar Sangamo Therapeutics SGMO|Target konsensus Nautilus Bio|MGX - Konsensus nilai wajar|Target konsensus Precision BioSciences Inc. (DTIL)|Rega prakiraan analis Generation Bio Co.|Prakiraan konsensus analis Boundless Bio Inc (BOLD)|Konsensus nilai wajar Exicure|Prakiraan konsensus analis Imunon Inc IMNN|PHIO (RXi Pharmaceuticals) - Rata-rata rega prakiraan|MBIO: Bagan rega target|Konsensus nilai wajar transcodetherapeutics.com RNAZ|Bionano Genomics (BNGO) - Prakiraan konsensus analis|APDN (Applied DNA Sciences) - Prakiraan konsensus analis|Bagan rega target BLUE|IPA - Bagan tingkat prakiraan|Prakiraan konsensus analis Omega Therapeutics Inc (OMGA)|OMIC: Rata-rata rega prakiraan|RGLS - Target konsensus|Syros Pharmaceuticals - Prakiraan konsensus analis|telesisbio.com (TBIO) - Target konsensus|TCON - Rega prakiraan analis|Unity Biotechnology Inc. (UBX) - Prakiraan konsensus analis